🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
✕
Login
Home
News
Messages
Startup Showcase
Trackers
Premium
Premium Content
Jobs
Notifications
Settings
Try our Valuation Calculator →
Log In
News on Medial
See potential in Indian single-specialty healthcare bets: Bain & Company's Arjun Upmanyu
VCCircle
·
1y ago
Medial
Consulting firm Bain & Company predicts that traditional sectors such as healthcare and advanced manufacturing will thrive in the Indian private equity and venture capital landscape in 2024. In a recent report, they stated that these sectors will emerge as outliers in an otherwise cautious environment. Bain & Company believes that there is great potential in single-specialty healthcare bets in India.
View Source
Related News
Big money is making a beeline for Indian hospitals
Economic Times
·
16d ago
Medial
India's hospital sector is experiencing significant investment and consolidation, emerging as a lucrative market. High-profile acquisitions include Manipal Health Enterprises' bid for Sahyadri Hospitals and KKR's acquisition of Healthcare Global. The sector attracted $4.96 billion from private equity and $3.2 billion in FDI from 2022-24. Single-specialty hospitals are in demand due to growth potential in tier 2/3 cities. The government's push for medical tourism and rising demand for quality healthcare services fuel sector growth.
View Source
Bain-controlled Novopor acquires US-based specialty chemicals company
VCCircle
·
2m ago
Medial
Bain-controlled Novopor Advanced Science Pvt Ltd has acquired US-based Pressure Chemical Company, a specialist in high-pressure and specialty chemistry services. This acquisition aligns with Novopor's strategy to establish an integrated specialty chemicals platform, enhancing its facilities and technical capabilities. Originally Porus Labs, Novopor collaborates with global clients across various sectors and operates R&D centres in India. Despite a revenue decline, Novopor achieved profitability in FY24 under Bain Capital's majority ownership.
View Source
GIC bets over $100 mn on Indian healthcare company
VCCircle
·
2m ago
Medial
GIC, Singapore's sovereign wealth fund, has significantly invested over $100 million in an Indian healthcare company, which also counts Temasek, another major Singaporean state investment firm, as a key shareholder. GIC's move underscores its active investment strategy in India, especially in the healthcare sector. This collaboration highlights the increasing interest and confidence of global investors in India's burgeoning healthcare industry, aiming to capitalize on its growth potential and innovation.
View Source
Why India's healthcare investment landscape may see key shifts in 2025
VCCircle
·
6m ago
Medial
India's healthcare investment landscape is poised for significant shifts in 2025, driven by increased spending due to a growing population, aging demographics, and greater awareness of health and wellness. Consolidation in diagnostics and single-specialty sectors, opportunities in pharmaceuticals, and the rise of AI in healthcare are key trends. These factors, along with India's manufacturing capabilities and strategic investments, position the country as a pivotal healthcare hub, offering robust investment prospects amid global and domestic market dynamics.
View Source
Bain, Inventia plan pharma bets; promoters to up stake in Zee
VCCircle
·
1y ago
Medial
Bain Capital is likely to acquire a stake in Sai Life Sciences, valuing the company at around $800 million. Platinum Equity Advisors is in talks to acquire drugmaker Inventia Healthcare. Zee Entertainment plans to sue Sony for damages, accusing them of preventing the merger. Lightspeed Venture Partners is exploring ways to sell startup stakes valued at approximately $1 billion.
View Source
Outlook 2025: Why healthcare deals will stay in limelight and what trends will play out
VCCircle
·
6m ago
Medial
The healthcare sector in 2024 saw significant deal activity driven by demand changes and patient needs, particularly in specialty hospitals and medical devices. Key trends anticipated for 2025 include increased investments in single-specialty hospitals, diagnostic chains, and medtech. Emerging areas like AI-driven diagnostics and precision medicine are poised to attract interest. Despite regulatory challenges, premium valuations are expected to continue for high-quality assets. The year is set to be transformative, fueled by digital integration and strategic consolidations.
View Source
Bain Capital brings new CEO for Porus Labs after buyout
VCCircle
·
1y ago
Medial
Private equity firm Bain Capital has appointed a new CEO for Porus Labs, a manufacturer of agricultural and specialty chemicals based in Hyderabad. Bain Capital acquired a majority stake in the company in June 2020. The specific deal value of the acquisition is estimated to be between Rs 2,500 crore and Rs. 3,000 crore.
View Source
360 One Asset's Tarun Sharma on investment thesis, sweet spots in Indian healthcare and more
VCCircle
·
7m ago
Medial
360 One Asset is raising capital for its Healthcare Opportunities Fund, with a target of Rs 1,000 crore ($118 million). The fund will focus on investments in the Indian healthcare sector. Tarun Sharma, head of healthcare and consumer at 360 One Asset, discusses the investment thesis and the sweet spots in the Indian healthcare industry. The firm, backed by private equity giant Bain Capital, aims to capitalize on the opportunities in the growing healthcare market in India.
View Source
EQT to pare stake in Sagility; Piramal-Bain JV India RF eyes stake in Anthea
VCCircle
·
1y ago
Medial
Swedish private equity firm EQT is planning to reduce its stake in Sagility (formerly Hinduja Global Solutions Healthcare) through an initial public offering (IPO) process. This move is expected to value the healthcare business process management firm at around $3 billion. Additionally, Piramal-Bain joint venture India RF is reportedly eyeing a stake in Anthea, indicating a potential investment in the healthcare sector.
View Source
Deals Digest: PE bets in healthcare, cross-border M&As top the charts
VCCircle
·
4m ago
Medial
Private equity investments in the healthcare sector and cross-border mergers and acquisitions dominated deal-making activities during the week ending February 28. The total transaction value more than doubled compared to the previous week, reaching $564 million, as per VCCircle data. A notable single deal significantly contributed to this surge in activity, highlighting the ongoing investor interest in healthcare and international market expansions.
View Source
Trackers
Active Indian VC’s
OG Capital
Email
With a hands-on approach, OG Capital aims to invest in over 20 promising...
Accel Partners
Email
Early and growth-stage investments in disruptive technology companies with...
Blume
Email
Early-stage venture capital firm investing in technology startups in India. Focus on...
Access All Trackers
Startup Showcase Winners
June 2025
Buddy
Helping your parents when you are miles away
BiteStop
The Pit Stop Your Cravings Deserve
Bloomer
The next generation E-commerce platform
Enter Ongoing Startup Showcase
Top Users
Trending News on Medial
Download the medial app to read full posts, comements and news.
Go to Medial App
Not Now
Know everything that’s happening in the startup ecosystem, first.
Enable Notifications?
No, thanks
Count me in
